Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

Mss51 deletion enhances muscle metabolism and glucose homeostasis in mice.

Rovira Gonzalez YI, Moyer AL, LeTexier NJ, Bratti AD, Feng S, Sun C, Liu T, Mula J, Jha P, Iyer SR, Lovering RM, O'Rourke B, Noh HL, Suk S, Kim JK, Umanah GK, Wagner KR.

JCI Insight. 2019 Sep 17. pii: 122247. doi: 10.1172/jci.insight.122247. [Epub ahead of print]

2.

The NIH Toolbox for cognitive surveillance in Duchenne muscular dystrophy.

Thangarajh M, Kaat AJ, Bibat G, Mansour J, Summerton K, Gioia A, Berger C, Hardy KK, Wagner KR.

Ann Clin Transl Neurol. 2019 Aug 31. doi: 10.1002/acn3.50867. [Epub ahead of print]

3.

Benign tumors in myotonic dystrophy type I target disease-related cancer sites.

Alsaggaf R, St George DMM, Zhan M, Pfeiffer RM, Wang Y, Anderson LA, Liu Z, Koshiol J, Bauer AJ, Wagner KR, Greene MH, Amr S, Gadalla SM.

Ann Clin Transl Neurol. 2019 Aug;6(8):1510-1518. doi: 10.1002/acn3.50856. Epub 2019 Jul 26.

4.

AAV9 Edits Muscle Stem Cells in Normal and Dystrophic Adult Mice.

Nance ME, Shi R, Hakim CH, Wasala NB, Yue Y, Pan X, Zhang T, Robinson CA, Duan SX, Yao G, Yang NN, Chen SJ, Wagner KR, Gersbach CA, Duan D.

Mol Ther. 2019 Sep 4;27(9):1568-1585. doi: 10.1016/j.ymthe.2019.06.012. Epub 2019 Jul 3.

PMID:
31327755
5.

Long-read single-molecule maps of the functional methylome.

Sharim H, Grunwald A, Gabrieli T, Michaeli Y, Margalit S, Torchinsky D, Arielly R, Nifker G, Juhasz M, Gularek F, Almalvez M, Dufault B, Chandra SS, Liu A, Bhattacharya S, Chen YW, Vilain E, Wagner KR, Pevsner J, Reifenberger J, Lam ET, Hastie AR, Cao H, Barseghyan H, Weinhold E, Ebenstein Y.

Genome Res. 2019 Apr;29(4):646-656. doi: 10.1101/gr.240739.118. Epub 2019 Mar 7.

6.

Cancer Risk in Myotonic Dystrophy Type I: Evidence of a Role for Disease Severity.

Alsaggaf R, St George DMM, Zhan M, Pfeiffer RM, Wang Y, Wagner KR, Greene MH, Amr S, Gadalla SM.

JNCI Cancer Spectr. 2018 Nov;2(4):pky052. doi: 10.1093/jncics/pky052. Epub 2018 Dec 10.

PMID:
30556050
7.

Adipose-derived Stem/Stromal Cells on Electrospun Fibrin Microfiber Bundles Enable Moderate Muscle Reconstruction in a Volumetric Muscle Loss Model.

Gilbert-Honick J, Ginn B, Zhang Y, Salehi S, Wagner KR, Mao HQ, Grayson WL.

Cell Transplant. 2018 Oct 9:963689718805370. doi: 10.1177/0963689718805370. [Epub ahead of print]

8.

A Transition Toolkit for Duchenne Muscular Dystrophy.

Trout CJ, Case LE, Clemens PR, McArthur A, Noritz G, Ritzo M, Wagner KR, Vroom E, Kennedy A.

Pediatrics. 2018 Oct;142(Suppl 2):S110-S117. doi: 10.1542/peds.2018-0333M.

PMID:
30275255
9.

Cardiac Management of the Patient With Duchenne Muscular Dystrophy.

Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, Hor K, Judge DP, Kinnett K, McNally EM, Raman S, Thompson WR, Wagner KR, Olson AK.

Pediatrics. 2018 Oct;142(Suppl 2):S72-S81. doi: 10.1542/peds.2018-0333I. Review.

PMID:
30275251
10.

Neurology Care, Diagnostics, and Emerging Therapies of the Patient With Duchenne Muscular Dystrophy.

Leigh F, Ferlini A, Biggar D, Bushby K, Finkel R, Morgenroth LP, Wagner KR.

Pediatrics. 2018 Oct;142(Suppl 2):S5-S16. doi: 10.1542/peds.2018-0333C.

PMID:
30275245
11.

Biological scaffold-mediated delivery of myostatin inhibitor promotes a regenerative immune response in an animal model of Duchenne muscular dystrophy.

Estrellas KM, Chung L, Cheu LA, Sadtler K, Majumdar S, Mula J, Wolf MT, Elisseeff JH, Wagner KR.

J Biol Chem. 2018 Oct 5;293(40):15594-15605. doi: 10.1074/jbc.RA118.004417. Epub 2018 Aug 23.

PMID:
30139748
12.

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.

Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, Case LE, Clemens PR, Hadjiyannakis S, Pandya S, Street N, Tomezsko J, Wagner KR, Ward LM, Weber DR; DMD Care Considerations Working Group.

Lancet Neurol. 2018 Mar;17(3):251-267. doi: 10.1016/S1474-4422(18)30024-3. Epub 2018 Feb 3. Review. Erratum in: Lancet Neurol. 2018 Apr 4;:.

13.

Multivoxel proton magnetic resonance spectroscopy in facioscapulohumeral muscular dystrophy.

Leung DG, Wang X, Barker PB, Carrino JA, Wagner KR.

Muscle Nerve. 2018 Jun;57(6):958-963. doi: 10.1002/mus.26048. Epub 2018 Feb 14.

14.

Comparison of Perioperative Outcomes Between Holmium Laser Enucleation of the Prostate and Robot-Assisted Simple Prostatectomy.

Zhang MW, El Tayeb MM, Borofsky MS, Dauw CA, Wagner KR, Lowry PS, Bird ET, Hudson TC, Lingeman JE.

J Endourol. 2017 Sep;31(9):847-850. doi: 10.1089/end.2017.0095. Epub 2017 Jul 19.

PMID:
28637364
15.

Robotic repair of vesicovaginal fistulas using fibrin sealant.

Machen GL, Chiles LR, Joyce J, Wagner KR.

Can J Urol. 2017 Apr;24(2):8740-8743.

PMID:
28436361
16.

Bone health in facioscapulohumeral muscular dystrophy: A cross-sectional study.

Chagarlamudi H, Corbett A, Stoll M, Bibat G, Grosmann C, Matichak Stock C, Stinson N, Shapiro J, Wagner KR.

Muscle Nerve. 2017 Dec;56(6):1108-1113. doi: 10.1002/mus.25619. Epub 2017 Jun 5.

PMID:
28214289
17.

Left Ventricular Dysfunction and Conduction Disturbances in Patients With Myotonic Muscular Dystrophy Type I and II.

Tanawuttiwat T, Wagner KR, Tomaselli G, Nazarian S.

JAMA Cardiol. 2017 Feb 1;2(2):225-228. doi: 10.1001/jamacardio.2016.4145. No abstract available.

PMID:
27829084
18.

Urinary Catheterization: a Paradigm Shift in Difficult Urinary Catheterization.

Wagner KR, Bird ET, Coffield KS.

Curr Urol Rep. 2016 Nov;17(11):82. Review.

PMID:
27665577
19.

Validity of the 6 minute walk test in facioscapulohumeral muscular dystrophy.

Eichinger K, Heatwole C, Heininger S, Stinson N, Matichak Stock C, Grosmann C, Wagner KR, Tawil R, Statland JM; FSHD Clinical Trials Research Network.

Muscle Nerve. 2017 Mar;55(3):333-337. doi: 10.1002/mus.25251. Epub 2016 Dec 5.

20.

Morpholino-mediated Knockdown of DUX4 Toward Facioscapulohumeral Muscular Dystrophy Therapeutics.

Chen JC, King OD, Zhang Y, Clayton NP, Spencer C, Wentworth BM, Emerson CP Jr, Wagner KR.

Mol Ther. 2016 Aug;24(8):1405-11. doi: 10.1038/mt.2016.111. Epub 2016 Jun 3.

21.

Concordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient-Specific Myoblasts Derived using a Human iPSC-Based Model.

Choi IY, Lim H, Estrellas K, Mula J, Cohen TV, Zhang Y, Donnelly CJ, Richard JP, Kim YJ, Kim H, Kazuki Y, Oshimura M, Li HL, Hotta A, Rothstein J, Maragakis N, Wagner KR, Lee G.

Cell Rep. 2016 Jun 7;15(10):2301-2312. doi: 10.1016/j.celrep.2016.05.016. Epub 2016 May 26.

22.

Clinical practice considerations in facioscapulohumeral muscular dystrophy Sydney, Australia, 21 September 2015.

Tawil R, Mah JK, Baker S, Wagner KR, Ryan MM; Sydney Workshop Participants.

Neuromuscul Disord. 2016 Jul;26(7):462-71. doi: 10.1016/j.nmd.2016.03.007. Epub 2016 Apr 25. No abstract available.

PMID:
27185458
23.

In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy.

Choudhury SR, Fitzpatrick Z, Harris AF, Maitland SA, Ferreira JS, Zhang Y, Ma S, Sharma RB, Gray-Edwards HL, Johnson JA, Johnson AK, Alonso LC, Punzo C, Wagner KR, Maguire CA, Kotin RM, Martin DR, Sena-Esteves M.

Mol Ther. 2016 Aug;24(7):1247-57. doi: 10.1038/mt.2016.84. Epub 2016 Apr 27.

24.

Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells.

Sadtler K, Estrellas K, Allen BW, Wolf MT, Fan H, Tam AJ, Patel CH, Luber BS, Wang H, Wagner KR, Powell JD, Housseau F, Pardoll DM, Elisseeff JH.

Science. 2016 Apr 15;352(6283):366-70. doi: 10.1126/science.aad9272.

25.

Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.

Kornegay JN, Bogan DJ, Bogan JR, Dow JL, Wang J, Fan Z, Liu N, Warsing LC, Grange RW, Ahn M, Balog-Alvarez CJ, Cotten SW, Willis MS, Brinkmeyer-Langford C, Zhu H, Palandra J, Morris CA, Styner MA, Wagner KR.

Skelet Muscle. 2016 Apr 4;6:14. doi: 10.1186/s13395-016-0085-7. eCollection 2016.

26.

Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease.

Mammen AL, Casciola-Rosen L, Christopher-Stine L, Lloyd TE, Wagner KR.

Neurol Neuroimmunol Neuroinflamm. 2015 Nov 19;2(6):e172. doi: 10.1212/NXI.0000000000000172. eCollection 2015 Dec.

27.

Mammalian Mss51 is a skeletal muscle-specific gene modulating cellular metabolism.

Moyer AL, Wagner KR.

J Neuromuscul Dis. 2015;2(4):371-385. Epub 2015 Sep 21.

28.

Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy.

McNally EM, Kaltman JR, Benson DW, Canter CE, Cripe LH, Duan D, Finder JD, Groh WJ, Hoffman EP, Judge DP, Kertesz N, Kinnett K, Kirsch R, Metzger JM, Pearson GD, Rafael-Fortney JA, Raman SV, Spurney CF, Targum SL, Wagner KR, Markham LW; Working Group of the National Heart, Lung, and Blood Institute; Parent Project Muscular Dystrophy.

Circulation. 2015 May 5;131(18):1590-8. doi: 10.1161/CIRCULATIONAHA.114.015151. No abstract available. Erratum in: Circulation. 2015 Jun 23;131(25):e539. Groh, William J [added].

29.

Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy.

Jones TI, King OD, Himeda CL, Homma S, Chen JC, Beermann ML, Yan C, Emerson CP Jr, Miller JB, Wagner KR, Jones PL.

Clin Epigenetics. 2015 Mar 29;7:37. doi: 10.1186/s13148-015-0072-6. eCollection 2015.

30.

The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development.

Heslop E, Csimma C, Straub V, McCall J, Nagaraju K, Wagner KR, Caizergues D, Korinthenberg R, Flanigan KM, Kaufmann P, McNeil E, Mendell J, Hesterlee S, Wells DJ, Bushby K; TACT.

Orphanet J Rare Dis. 2015 Apr 23;10:49. doi: 10.1186/s13023-015-0258-1. Review.

31.

Genetic disruption of Smad7 impairs skeletal muscle growth and regeneration.

Cohen TV, Kollias HD, Liu N, Ward CW, Wagner KR.

J Physiol. 2015 Jun 1;593(11):2479-97. doi: 10.1113/JP270201. Epub 2015 May 15.

32.

Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy.

Leung DG, Carrino JA, Wagner KR, Jacobs MA.

Muscle Nerve. 2015 Oct;52(4):512-20. doi: 10.1002/mus.24569. Epub 2015 Mar 31.

33.

Telomere position effect: regulation of gene expression with progressive telomere shortening over long distances.

Robin JD, Ludlow AT, Batten K, Magdinier F, Stadler G, Wagner KR, Shay JW, Wright WE.

Genes Dev. 2014 Nov 15;28(22):2464-76. doi: 10.1101/gad.251041.114.

34.

Results of a two-year pilot study of clinical outcome measures in collagen VI- and laminin alpha2-related congenital muscular dystrophies.

Meilleur KG, Jain MS, Hynan LS, Shieh CY, Kim E, Waite M, McGuire M, Fiorini C, Glanzman AM, Main M, Rose K, Duong T, Bendixen R, Linton MM, Arveson IC, Nichols C, Yang K, Fischbeck KH, Wagner KR, North K, Mankodi A, Grunseich C, Hartnett EJ, Smith M, Donkervoort S, Schindler A, Kokkinis A, Leach M, Foley AR, Collins J, Muntoni F, Rutkowski A, Bönnemann CG.

Neuromuscul Disord. 2015 Jan;25(1):43-54. doi: 10.1016/j.nmd.2014.09.010. Epub 2014 Sep 28.

35.

Sildenafil does not improve cardiomyopathy in Duchenne/Becker muscular dystrophy.

Leung DG, Herzka DA, Thompson WR, He B, Bibat G, Tennekoon G, Russell SD, Schuleri KH, Lardo AC, Kass DA, Thompson RE, Judge DP, Wagner KR.

Ann Neurol. 2014 Oct;76(4):541-9. doi: 10.1002/ana.24214. Epub 2014 Jul 10.

36.

Administration of S-methyl-L-thiocitrulline protects against brain injuries after intracerebral hemorrhage.

Lu A, Wagner KR, Broderick JP, Clark JF.

Neuroscience. 2014 Jun 13;270:40-7. doi: 10.1016/j.neuroscience.2014.04.004. Epub 2014 Apr 13.

37.

Novel mutations widen the phenotypic spectrum of slow skeletal/β-cardiac myosin (MYH7) distal myopathy.

Lamont PJ, Wallefeld W, Hilton-Jones D, Udd B, Argov Z, Barboi AC, Bonneman C, Boycott KM, Bushby K, Connolly AM, Davies N, Beggs AH, Cox GF, Dastgir J, DeChene ET, Gooding R, Jungbluth H, Muelas N, Palmio J, Penttilä S, Schmedding E, Suominen T, Straub V, Staples C, Van den Bergh PY, Vilchez JJ, Wagner KR, Wheeler PG, Wraige E, Laing NG.

Hum Mutat. 2014 Jul;35(7):868-79. doi: 10.1002/humu.22553. Epub 2014 May 21.

38.

Magnetic resonance imaging phenotyping of Becker muscular dystrophy.

Faridian-Aragh N, Wagner KR, Leung DG, Carrino JA.

Muscle Nerve. 2014 Dec;50(6):962-7. doi: 10.1002/mus.24246. Epub 2014 Oct 30.

PMID:
24659522
39.

Human skeletal muscle xenograft as a new preclinical model for muscle disorders.

Zhang Y, King OD, Rahimov F, Jones TI, Ward CW, Kerr JP, Liu N, Emerson CP Jr, Kunkel LM, Partridge TA, Wagner KR.

Hum Mol Genet. 2014 Jun 15;23(12):3180-8. doi: 10.1093/hmg/ddu028. Epub 2014 Jan 22.

40.

'Double trouble': diagnostic challenges in Duchenne muscular dystrophy in patients with an additional hereditary skeletal dysplasia.

Donkervoort S, Schindler A, Tesi-Rocha C, Schreiber A, Leach ME, Dastgir J, Hu Y, Mankodi A, Wagner KR, Friedman NR, Bönnemann CG.

Neuromuscul Disord. 2013 Dec;23(12):955-61. doi: 10.1016/j.nmd.2013.08.003. Epub 2013 Aug 11.

41.

Matrix metalloproteinase-2 deletions protect against hemorrhagic transformation after 1 h of cerebral ischemia and 23 h of reperfusion.

Lu A, Suofu Y, Guan F, Broderick JP, Wagner KR, Clark JF.

Neuroscience. 2013 Dec 3;253:361-7. doi: 10.1016/j.neuroscience.2013.08.068. Epub 2013 Sep 12.

42.

Therapeutic advances in muscular dystrophy.

Leung DG, Wagner KR.

Ann Neurol. 2013 Sep;74(3):404-11. doi: 10.1002/ana.23989. Review.

43.

Myostatin-Related Muscle Hypertrophy.

Wagner KR, Cohen JS.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
2005 Oct 5 [updated 2013 Jul 3].

44.

Telomere position effect regulates DUX4 in human facioscapulohumeral muscular dystrophy.

Stadler G, Rahimov F, King OD, Chen JC, Robin JD, Wagner KR, Shay JW, Emerson CP Jr, Wright WE.

Nat Struct Mol Biol. 2013 Jun;20(6):671-8. doi: 10.1038/nsmb.2571. Epub 2013 May 5.

45.

ANO5 gene analysis in a large cohort of patients with anoctaminopathy: confirmation of male prevalence and high occurrence of the common exon 5 gene mutation.

Sarkozy A, Hicks D, Hudson J, Laval SH, Barresi R, Hilton-Jones D, Deschauer M, Harris E, Rufibach L, Hwang E, Bashir R, Walter MC, Krause S, van den Bergh P, Illa I, Pénisson-Besnier I, De Waele L, Turnbull D, Guglieri M, Schrank B, Schoser B, Seeger J, Schreiber H, Gläser D, Eagle M, Bailey G, Walters R, Longman C, Norwood F, Winer J, Muntoni F, Hanna M, Roberts M, Bindoff LA, Brierley C, Cooper RG, Cottrell DA, Davies NP, Gibson A, Gorman GS, Hammans S, Jackson AP, Khan A, Lane R, McConville J, McEntagart M, Al-Memar A, Nixon J, Panicker J, Parton M, Petty R, Price CJ, Rakowicz W, Ray P, Schapira AH, Swingler R, Turner C, Wagner KR, Maddison P, Shaw PJ, Straub V, Bushby K, Lochmüller H.

Hum Mutat. 2013 Aug;34(8):1111-8. doi: 10.1002/humu.22342. Epub 2013 Jun 12.

PMID:
23606453
46.

Fast skeletal muscle troponin activator in the dy2J muscular dystrophy model.

Miciak JJ, Warsing LC, Tibbs ME, Jasper JR, Jampel SB, Malik FI, Tankersley C, Wagner KR.

Muscle Nerve. 2013 Aug;48(2):279-85. doi: 10.1002/mus.23848. Epub 2013 Jun 29.

PMID:
23512724
47.

Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy.

Statland JM, McDermott MP, Heatwole C, Martens WB, Pandya S, van der Kooi EL, Kissel JT, Wagner KR, Tawil R.

Neuromuscul Disord. 2013 Apr;23(4):306-12. doi: 10.1016/j.nmd.2013.01.008. Epub 2013 Feb 11.

48.

Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers.

Rahimov F, King OD, Leung DG, Bibat GM, Emerson CP Jr, Kunkel LM, Wagner KR.

Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16234-9. doi: 10.1073/pnas.1209508109. Epub 2012 Sep 17.

49.

Incomplete degeneration versus enhanced regeneration in skeletal muscle.

Moyer AL, Wagner KR.

J Biol Chem. 2012 Jul 20;287(30):25549; author reply 25550. doi: 10.1074/jbc.L112.380923. No abstract available.

50.

Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis.

Jones TI, Chen JC, Rahimov F, Homma S, Arashiro P, Beermann ML, King OD, Miller JB, Kunkel LM, Emerson CP Jr, Wagner KR, Jones PL.

Hum Mol Genet. 2012 Oct 15;21(20):4419-30. Epub 2012 Jul 13.

Supplemental Content

Loading ...
Support Center